These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1387255)

  • 1. Treatment of autoimmune diseases with intravenous gammaglobulin.
    Gelfand EW
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):127-33. PubMed ID: 1387255
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell tolerance: models for clinical application to allergy and autoimmunity.
    Schad VC
    Chem Immunol; 1994; 58():193-205. PubMed ID: 8011152
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.
    Kazatchkine MD; Kaveri SV
    N Engl J Med; 2001 Sep; 345(10):747-55. PubMed ID: 11547745
    [No Abstract]   [Full Text] [Related]  

  • 6. alpha beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity.
    Peng SL; McNiff JM; Madaio MP; Ma J; Owen MJ; Flavell RA; Hayday AC; Craft J
    J Immunol; 1997 Mar; 158(5):2464-70. PubMed ID: 9036998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous immunoglobulins (IgIV) in the treatment of autoimmune diseases and systemic inflammatory diseases].
    Kazatchkine M
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):209-10. PubMed ID: 8337128
    [No Abstract]   [Full Text] [Related]  

  • 8. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A change in the expression of histocompatibility antigens could lead to autoimmunity].
    Pujol-Borrell R; Bottazzo GF; Feldmann M
    Med Clin (Barc); 1984 Apr; 82(13):594-5. PubMed ID: 6610082
    [No Abstract]   [Full Text] [Related]  

  • 10. Can intravenous immunoglobulin treatment regulate autoimmune responses?
    Kaveri SV; Dietrich G; Kazatchkine MD
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):64-71. PubMed ID: 1509296
    [No Abstract]   [Full Text] [Related]  

  • 11. Expansion/deletion of mature T cells exposed to endogenous superantigens in vivo.
    Webb SR; Hutchinson J; Hayden K; Sprent J
    J Immunol; 1994 Jan; 152(2):586-97. PubMed ID: 8283040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein may help prevent autoimmune attacks.
    Dent Today; 2004 Jun; 23(6):34. PubMed ID: 15218667
    [No Abstract]   [Full Text] [Related]  

  • 13. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.
    Shoenfeld Y; Blank M; Abu-Shakra M; Amital H; Barzilai O; Berkun Y; Bizzaro N; Gilburd B; Zandman-Goddard G; Katz U; Krause I; Langevitz P; Mackay IR; Orbach H; Ram M; Sherer Y; Toubi E; Gershwin ME
    Isr Med Assoc J; 2008 Jan; 10(1):13-9. PubMed ID: 18300564
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunology. Now presenting: gammadelta T cells.
    Modlin RL; Sieling PA
    Science; 2005 Jul; 309(5732):252-3. PubMed ID: 16002604
    [No Abstract]   [Full Text] [Related]  

  • 15. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of antigen-specific therapies for autoimmune disease.
    Steinman L
    Mol Biol Med; 1990 Aug; 7(4):333-9. PubMed ID: 2233245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerogenic dendritic cells for autoimmune disease and transplantation.
    Thomson AW; Robbins PD
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases.
    Fowler E; Weiner HL
    Biopolymers; 1997; 43(4):323-35. PubMed ID: 9316395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune system and intravenous administration of immune globulin. Part I, The immune system.
    Frey AM
    J Intraven Nurs; 1991; 14(5):315-30. PubMed ID: 1748915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.